Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha Demethylase

<i>Candida</i> species cause an opportunistic yeast infection called Candidiasis, which is responsible for more than 50,000 deaths every year around the world. Effective treatments against candidiasis caused by non-albicans <i>Candida</i> species such as <i>C. glabrata,...

Full description

Bibliographic Details
Main Authors: Victor Marin, Andres Iturra, Andres Opazo, Bernd Schmidt, Matthias Heydenreich, Leandro Ortiz, Verónica A. Jiménez, Cristian Paz
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Biomolecules
Subjects:
Online Access:https://www.mdpi.com/2218-273X/10/8/1101
_version_ 1797561462371123200
author Victor Marin
Andres Iturra
Andres Opazo
Bernd Schmidt
Matthias Heydenreich
Leandro Ortiz
Verónica A. Jiménez
Cristian Paz
author_facet Victor Marin
Andres Iturra
Andres Opazo
Bernd Schmidt
Matthias Heydenreich
Leandro Ortiz
Verónica A. Jiménez
Cristian Paz
author_sort Victor Marin
collection DOAJ
description <i>Candida</i> species cause an opportunistic yeast infection called Candidiasis, which is responsible for more than 50,000 deaths every year around the world. Effective treatments against candidiasis caused by non-albicans <i>Candida</i> species such as <i>C. glabrata, C. parapsilosis, C. aureus,</i> and <i>C.</i> <i>krusei</i> are limited due to severe resistance to conventional antifungal drugs. Natural drimane sesquiterpenoids have shown promising antifungal properties against <i>Candida</i> yeast and have emerged as valuable candidates for developing new candidiasis therapies. In this work, we isolated isodrimeninol (<b>C1</b>) from barks of <i>Drimys winteri</i> and used it as starting material for the hemi-synthesis of four sesquiterpenoids by oxidation with pyridinium chlorochromate (PCC). The structure of the products (<b>C2</b>, <b>C3</b>, <b>C4,</b> and <b>C5</b>) was elucidated by 1D and 2D NMR spectroscopy resulting in <b>C4</b> being a novel compound. Antifungal activity assays against <i>C. albicans, C. glabrata,</i> and <i>C. krusei</i> revealed that <b>C4</b> exhibited an increased activity (IC<sub>50</sub> of 75 μg/mL) compared to <b>C1</b> (IC<sub>50</sub> of 125 μg/mL) in all yeast strains. The antifungal activity of <b>C1</b> and <b>C4</b> was rationalized in terms of their capability to inhibit lanosterol 14-alpha demethylase using molecular docking, molecular dynamics simulations, and MM/GBSA binding free energy calculations. In silico analysis revealed that <b>C1</b> and <b>C4</b> bind to the outermost region of the catalytic site of 14-alpha demethylase and block the entrance of lanosterol (<b>LAN</b>) to the catalytic pocket. Binding free energy estimates suggested that <b>C4</b> forms a more stable complex with the enzyme than <b>C1</b>, in agreement with the experimental evidence. Based on this new approach it is possible to design new drimane-type sesquiterpenoids for the control of <i>Candida</i> species as inhibitors of 14-alpha demethylase.
first_indexed 2024-03-10T18:14:18Z
format Article
id doaj.art-b0051dd1542b44d19f234fce1b2972a8
institution Directory Open Access Journal
issn 2218-273X
language English
last_indexed 2024-03-10T18:14:18Z
publishDate 2020-07-01
publisher MDPI AG
record_format Article
series Biomolecules
spelling doaj.art-b0051dd1542b44d19f234fce1b2972a82023-11-20T07:50:36ZengMDPI AGBiomolecules2218-273X2020-07-01108110110.3390/biom10081101Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha DemethylaseVictor Marin0Andres Iturra1Andres Opazo2Bernd Schmidt3Matthias Heydenreich4Leandro Ortiz5Verónica A. Jiménez6Cristian Paz7Laboratory of Natural Products & Drug Discovery, Department of Basic Science, Universidad de La Frontera, Av. Francisco Salazar 01145, 4780000 Temuco, ChileLaboratory of Natural Products & Drug Discovery, Department of Basic Science, Universidad de La Frontera, Av. Francisco Salazar 01145, 4780000 Temuco, ChileUniversidad de Concepción, Departamento de Microbiología, Laboratorio de Investigación en Agentes Antibacterianos (LIAA), Barrio Universitario S/N, 160-C 1807 Concepción, ChileUniversität Potsdam, Institut für Chemie, Karl-Liebknecht-Str. 24-25, D-14476 Potsdam, GermanyUniversität Potsdam, Institut für Chemie, Karl-Liebknecht-Str. 24-25, D-14476 Potsdam, GermanyUniversidad Austral de Chile, Instituto de Ciencias Química, Facultad de Ciencias, Universidad Austral de Chile, Casilla 567, 5091000 Valdivia, ChileUniversidad Andres Bello, Sede Concepción, Departamento de Ciencias Químicas, Facultad de Ciencias Exactas, Autopista Concepción-Talcahuano 7100, 4030000 Talcahuano, ChileLaboratory of Natural Products & Drug Discovery, Department of Basic Science, Universidad de La Frontera, Av. Francisco Salazar 01145, 4780000 Temuco, Chile<i>Candida</i> species cause an opportunistic yeast infection called Candidiasis, which is responsible for more than 50,000 deaths every year around the world. Effective treatments against candidiasis caused by non-albicans <i>Candida</i> species such as <i>C. glabrata, C. parapsilosis, C. aureus,</i> and <i>C.</i> <i>krusei</i> are limited due to severe resistance to conventional antifungal drugs. Natural drimane sesquiterpenoids have shown promising antifungal properties against <i>Candida</i> yeast and have emerged as valuable candidates for developing new candidiasis therapies. In this work, we isolated isodrimeninol (<b>C1</b>) from barks of <i>Drimys winteri</i> and used it as starting material for the hemi-synthesis of four sesquiterpenoids by oxidation with pyridinium chlorochromate (PCC). The structure of the products (<b>C2</b>, <b>C3</b>, <b>C4,</b> and <b>C5</b>) was elucidated by 1D and 2D NMR spectroscopy resulting in <b>C4</b> being a novel compound. Antifungal activity assays against <i>C. albicans, C. glabrata,</i> and <i>C. krusei</i> revealed that <b>C4</b> exhibited an increased activity (IC<sub>50</sub> of 75 μg/mL) compared to <b>C1</b> (IC<sub>50</sub> of 125 μg/mL) in all yeast strains. The antifungal activity of <b>C1</b> and <b>C4</b> was rationalized in terms of their capability to inhibit lanosterol 14-alpha demethylase using molecular docking, molecular dynamics simulations, and MM/GBSA binding free energy calculations. In silico analysis revealed that <b>C1</b> and <b>C4</b> bind to the outermost region of the catalytic site of 14-alpha demethylase and block the entrance of lanosterol (<b>LAN</b>) to the catalytic pocket. Binding free energy estimates suggested that <b>C4</b> forms a more stable complex with the enzyme than <b>C1</b>, in agreement with the experimental evidence. Based on this new approach it is possible to design new drimane-type sesquiterpenoids for the control of <i>Candida</i> species as inhibitors of 14-alpha demethylase.https://www.mdpi.com/2218-273X/10/8/1101IsodrimeninolPCC oxidation<i>Candida</i> yeastmolecular dockinglanosterol 14-alpha demethylase
spellingShingle Victor Marin
Andres Iturra
Andres Opazo
Bernd Schmidt
Matthias Heydenreich
Leandro Ortiz
Verónica A. Jiménez
Cristian Paz
Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha Demethylase
Biomolecules
Isodrimeninol
PCC oxidation
<i>Candida</i> yeast
molecular docking
lanosterol 14-alpha demethylase
title Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha Demethylase
title_full Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha Demethylase
title_fullStr Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha Demethylase
title_full_unstemmed Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha Demethylase
title_short Oxidation of Isodrimeninol with PCC Yields Drimane Derivatives with Activity against <i>Candida</i> Yeast by Inhibition of Lanosterol 14-Alpha Demethylase
title_sort oxidation of isodrimeninol with pcc yields drimane derivatives with activity against i candida i yeast by inhibition of lanosterol 14 alpha demethylase
topic Isodrimeninol
PCC oxidation
<i>Candida</i> yeast
molecular docking
lanosterol 14-alpha demethylase
url https://www.mdpi.com/2218-273X/10/8/1101
work_keys_str_mv AT victormarin oxidationofisodrimeninolwithpccyieldsdrimanederivativeswithactivityagainsticandidaiyeastbyinhibitionoflanosterol14alphademethylase
AT andresiturra oxidationofisodrimeninolwithpccyieldsdrimanederivativeswithactivityagainsticandidaiyeastbyinhibitionoflanosterol14alphademethylase
AT andresopazo oxidationofisodrimeninolwithpccyieldsdrimanederivativeswithactivityagainsticandidaiyeastbyinhibitionoflanosterol14alphademethylase
AT berndschmidt oxidationofisodrimeninolwithpccyieldsdrimanederivativeswithactivityagainsticandidaiyeastbyinhibitionoflanosterol14alphademethylase
AT matthiasheydenreich oxidationofisodrimeninolwithpccyieldsdrimanederivativeswithactivityagainsticandidaiyeastbyinhibitionoflanosterol14alphademethylase
AT leandroortiz oxidationofisodrimeninolwithpccyieldsdrimanederivativeswithactivityagainsticandidaiyeastbyinhibitionoflanosterol14alphademethylase
AT veronicaajimenez oxidationofisodrimeninolwithpccyieldsdrimanederivativeswithactivityagainsticandidaiyeastbyinhibitionoflanosterol14alphademethylase
AT cristianpaz oxidationofisodrimeninolwithpccyieldsdrimanederivativeswithactivityagainsticandidaiyeastbyinhibitionoflanosterol14alphademethylase